%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D8%A7%D9%84%D9%86%D8%AE%D8%A7%D8%B9_%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D8%B9%D8%B1%D8%B6K%C3%B6nd%C9%99l%C9%99l%C9%99n_mielitMielitis_transversaCategory:Transverse_myelitisTransverse_Myelitis%CE%95%CE%B3%CE%BA%CE%AC%CF%81%CF%83%CE%B9%CE%B1_%CE%BC%CF%85%CE%B5%CE%BB%CE%AF%CF%84%CE%B9%CE%B4%CE%B1Transverse_myelitisMielitis_transversa%D9%85%DB%8C%D9%84%DB%8C%D8%AA_%D8%B9%D8%B1%D8%B6%DB%8CMy%C3%A9lite_transverseMielite_trasversaMyelitis_transversaPoprzeczne_zapalenie_rdzeniaMielite_transversaTransvers_miyelitQ202217%E8%B2%AB%E7%A9%BF%E6%80%A7%E8%84%8A%E9%AB%93%E7%82%8E
about
P2175
New onset transverse myelitis diagnostic accuracy and patient experiencesSerum Auto-Antibodies in Neurological DiseasesCervical Myelopathy Caused by Intracranial Dural Arteriovenous Fistula with Acute Worsening After Steroid AdministrationScrambler Therapy for Treatment-Resistant Central Neuropathic Pain in a Patient with Transverse MyelitisUro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility studyPreventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)Longitudinally Extensive Transverse Myelitis (LETM) Following Varicella Infection in a 13-Year Immunocompetent ChildAn Open Label Extension Trial of Eculizumab in Relapsing NMO PatientsSurgical Treatment of Adult Trigger FingerThe Longitudinal CONQUER Study of Rare Neuroimmunologic DisordersSafety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)Long Term Study of Avonex Therapy Following a First Attack of Multiple SclerosisClinical Approach to Pediatric Transverse Myelitis, Neuromyelitis Optica Spectrum Disorder and Acute Flaccid MyelitisA Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum DisorderAn Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
P921
Q64040714-5415FD45-2791-496C-9669-2BEB0F5DC16AQ64042057-4EC8CF7C-FA71-4EE6-940C-0594471E3FA9Q64043140-F8DAAB0B-EE52-49D7-AC93-F66E3B4B864FQ64079041-F572C93E-9E5F-4284-B601-FF21959D8483Q64111124-FA332F59-D629-4AB1-91AE-96A796A4DB1CQ64217029-D37B56ED-968A-441A-B75B-F1B7DB32A0C8Q64226315-6EB815A1-766C-49C4-8DD1-058ED294DE7EQ64351760-8EED823E-C42E-4361-84A5-3EDE92818341Q64610295-730AAFA5-78C9-41EA-A4A4-D50C7FE6478FQ64644499-DC2B51B4-38E7-4CA1-991E-CBE4DA64181FQ65355112-3BFA0EE5-9EED-4B1F-B51F-590347A88A69Q66026078-6D28F58E-83DE-44EF-BC0E-DDE08B6BA088Q66680190-FFE56F01-29BE-4ED2-B0C5-04EE6ED3C2CCQ74132783-DB4C997C-97A2-4832-BF08-ADC1CE617858Q80365395-8FEB00D8-0754-4299-B473-DD4D6E0D1CCE
P921
description
Neurologische Erkrankung
@de
an inflammatory demyelinating ...... or secondary to a known cause
@en
name
Köndələlən mielit
@az
Mielite trasversa
@it
Mielitis transversa
@es
Myelitis transversa
@la
Poprzeczne zapalenie rdzenia
@pl
Transvers miyelit
@tr
Transverse Myelitis
@de
mielite transversa
@pt
mielitis transversa
@ca
myelitis traws
@cy
type
label
Köndələlən mielit
@az
Mielite trasversa
@it
Mielitis transversa
@es
Myelitis transversa
@la
Poprzeczne zapalenie rdzenia
@pl
Transvers miyelit
@tr
Transverse Myelitis
@de
mielite transversa
@pt
mielitis transversa
@ca
myelitis traws
@cy
altLabel
TM
@en
prefLabel
Köndələlən mielit
@az
Mielite trasversa
@it
Mielitis transversa
@es
Myelitis transversa
@la
Poprzeczne zapalenie rdzenia
@pl
Transvers miyelit
@tr
Transverse Myelitis
@de
mielite transversa
@pt
mielitis transversa
@ca
myelitis traws
@cy
P672
P486
P646
P672
P1550
P1748
P1995
P2176
P2888
P2892
P3827
transverse-myelitis
P4229
P486
P5270
MONDO:0015342
P646
P672
C04.588.614.550.550
C04.730.856.543
C10.114.375.600
C10.228.228.618.250
C10.228.854.525.553
C10.314.350.600
C10.574.781.625
C20.111.258.250.550